Ying Xia

484 total citations
27 papers, 303 citations indexed

About

Ying Xia is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Ying Xia has authored 27 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Ying Xia's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (4 papers). Ying Xia is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (4 papers). Ying Xia collaborates with scholars based in China, Sweden and United States. Ying Xia's co-authors include Hong‐Li Guo, Ya‐Hui Hu, Feng Chen, Jing Xu, Jianchun Yu, Yunhe Liu, Wentao Li, Huayu Chen, Rui Cheng and Xuansheng Ding and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Pharmacology and Current Pharmaceutical Design.

In The Last Decade

Ying Xia

27 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Xia China 11 117 85 55 53 52 27 303
Asunción Martín-Ruiz Spain 10 164 1.4× 70 0.8× 38 0.7× 73 1.4× 20 0.4× 13 370
Eyal Meiri United States 8 111 0.9× 49 0.6× 19 0.3× 26 0.5× 23 0.4× 14 289
Giusy Messina Italy 9 80 0.7× 121 1.4× 52 0.9× 9 0.2× 32 0.6× 36 368
Kazumi Fujita Japan 7 143 1.2× 12 0.1× 36 0.7× 70 1.3× 40 0.8× 12 368
Hualiang Jin China 12 78 0.7× 122 1.4× 50 0.9× 8 0.2× 12 0.2× 19 380
Virgil S. Lucas United States 8 135 1.2× 33 0.4× 37 0.7× 63 1.2× 26 0.5× 12 422
Haresh Jhangiani United States 6 67 0.6× 31 0.4× 10 0.2× 29 0.5× 24 0.5× 14 261
Chunyu Wang China 10 77 0.7× 93 1.1× 18 0.3× 10 0.2× 9 0.2× 32 300
Tarek Taha Israel 9 70 0.6× 34 0.4× 46 0.8× 18 0.3× 27 0.5× 32 471

Countries citing papers authored by Ying Xia

Since Specialization
Citations

This map shows the geographic impact of Ying Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Xia more than expected).

Fields of papers citing papers by Ying Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Xia. The network helps show where Ying Xia may publish in the future.

Co-authorship network of co-authors of Ying Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Xia. A scholar is included among the top collaborators of Ying Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Xia. Ying Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Changyu, Yutong Jin, Qian Cui, et al.. (2024). PI3K/AKT/mTOR and PD‑1/CTLA‑4/CD28 pathways as key targets of cancer immunotherapy (Review). Oncology Letters. 28(6). 567–567. 7 indexed citations
2.
3.
Cui, Qian, et al.. (2023). The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer. Immunity Inflammation and Disease. 11(11). e1099–e1099. 3 indexed citations
4.
Guo, Hong‐Li, Ya‐Hui Hu, Yun Liu, et al.. (2022). Caffeine Therapy for Apnea of Prematurity: Role of the Circadian CLOCK Gene Polymorphism. Frontiers in Pharmacology. 12. 724145–724145. 16 indexed citations
5.
Xia, Ying, Hong‐Li Guo, Jing Chen, et al.. (2022). An LC–ESI–MS/MS assay for the therapeutic drug monitoring of 15 antiseizure medications in plasma of children with epilepsy. Biomedical Chromatography. 36(12). e5484–e5484. 8 indexed citations
6.
Fu, Di, Hong‐Li Guo, Ya‐Hui Hu, et al.. (2022). The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review. Frontiers in Psychiatry. 12. 780921–780921. 38 indexed citations
7.
Xia, Ying, Wentao Li, Guan Zhang, et al.. (2022). The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients. Contrast Media & Molecular Imaging. 2022(1). 3444360–3444360. 12 indexed citations
8.
Zhang, Guan, Yanjie Yang, Ying Xia, et al.. (2022). Clinical predictive value of naïve and memory T cells in advanced NSCLC. Frontiers in Immunology. 13. 996348–996348. 19 indexed citations
9.
Yang, Qingyan, Ya‐Hui Hu, Hong‐Li Guo, et al.. (2021). Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor. Frontiers in Pharmacology. 12. 771487–771487. 17 indexed citations
10.
Xia, Ying, Hong‐Li Guo, Ya‐Hui Hu, et al.. (2021). Switching Between LC-ESI-MS/MS and EMIT Methods for Routine TDM of Valproic Acid in Pediatric Patients With Epilepsy: What Clinicians and Researchers Need to Know. Frontiers in Pharmacology. 12. 750744–750744. 6 indexed citations
11.
Guo, Hong‐Li, Xin He, Ya‐Hui Hu, et al.. (2021). Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors. Frontiers in Pharmacology. 12. 681842–681842. 26 indexed citations
12.
13.
Liu, Yunhe, Xiaoxue Guo, Wentao Li, et al.. (2020). Discovery and characteristics of B cell-like T cells: A potential novel tumor immune marker?. Immunology Letters. 220. 44–50. 10 indexed citations
14.
Xia, Ying, Wentao Li, Yongmin Li, et al.. (2020). The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer. Translational Oncology. 13(12). 100849–100849. 26 indexed citations
15.
16.
17.
18.
Xia, Ying, Chunyong Wu, Wenyuan Liu, Feng Feng, & Zhiyu Li. (2012). A novel process related impurity and forced degradation study of synthetic wogonin: Development of a liquid chromatographic method for purity control. Journal of Pharmaceutical and Biomedical Analysis. 71. 168–172. 7 indexed citations
19.
Wang, Hanping, Li Zhang, Fenlai Tan, et al.. (2011). Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer.. PubMed. 124(13). 1933–1933. 31 indexed citations
20.
Xia, Ying, et al.. (1986). An approach to the effect on tumors of acupuncture in combination with radiotherapy or chemotherapy.. PubMed. 6(1). 23–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asunción Martín-Ruiz Breakdown of academic impact, for papers by Eyal Meiri Breakdown of academic impact, for papers by Giusy Messina Breakdown of academic impact, for papers by Kazumi Fujita Breakdown of academic impact, for papers by Hualiang Jin Breakdown of academic impact, for papers by Virgil S. Lucas Breakdown of academic impact, for papers by Haresh Jhangiani Breakdown of academic impact, for papers by Chunyu Wang Breakdown of academic impact, for papers by Tarek Taha
Rankless by CCL
2026